Edition:
United Kingdom

People: Atara Biotherapeutics Inc (ATRA.OQ)

ATRA.OQ on NASDAQ Stock Exchange Global Select Market

13.06USD
23 Aug 2019
Change (% chg)

$-0.48 (-3.55%)
Prev Close
$13.54
Open
$13.51
Day's High
$13.67
Day's Low
$12.96
Volume
181,453
Avg. Vol
255,349
52-wk High
$43.85
52-wk Low
$11.89

Newell, Joseph 

Mr. Joseph Newell serves as Executive Vice President and Chief Technical Operations Officer of the Company. He has served as our EVP and Chief Technical Operations Officer since April 2017. From July 2015 to April 2017, he was Vice President, North America Manufacturing at Alexion Pharmaceuticals, Inc., a publicly traded biotechnology company. From March 2008 to July 2015, Mr. Newell served various roles within Amgen, Inc., a publicly traded human therapeutics company, including as Executive Director and Plant Manager from August 2012 to September 2014 and Executive Director, Operations Strategic Planning from September 2014 to June 2015. He received a B.S. from California State Polytechnic University – Pomona.

Basic Compensation

Total Annual Compensation, USD 520,490
Restricted Stock Award, USD 895,000
Long-Term Incentive Plans, USD --
All Other, USD 1,076,800
Fiscal Year Total, USD 2,492,290

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Pascal Touchon

--

Utpal Koppikar

4,220,280

Joseph Newell

2,492,290

Mina Kim

3,384,430

Derrell Porter

1,510,390

Dietmar Berger

4,972,440
As Of  31 Dec 2018